Rituximab and Belimumab Combination Therapy in PR3 Vasculitis
A Randomised, Double Blind, Controlled Mechanistic Study of Rituximab and Belimumab Combination Therapy in PR3 ANCA-associated Vasculitis A Randomised, Double Blind, Controlled Mechanistic Study of Rituximab and Belimumab Combination Ther ...
ANCA Associated Vasculitis;Granulomatosis With Polyangiitis
GlaxoSmithKline;Medical Research Council;Imperial College London;University College, London;Newcastle University;University of Glasgow;University of Cambridge GlaxoSmithKline;Medical Research Council;Imperial College London;University College, London;Newcastl ...
Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
Mepolizumab Long-term Access Programme for Subjects Who Participated in Study MEA115921 (Placebo-controlled Study of Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis in Subjects Receiving Standard-of-care Therapy) Mepolizumab Long-term Access Programme for Subjects Who Participated in Study MEA115921 (Placebo-con ...